Dechert has added Lucy (Qiong) Lu as a national partner in the corporate team. She will be a resident in the Beijing office. Lu has more than 13 years experience handling cross-border transactions in China. Her practice focuses on China outbound M&As, foreign direct investment into China and other cross-border transactions involving Chinese entities. She concentrates on PRC-related corporate matters, including M&As, private equity, restructuring and general corporate matters representing multinational companies and financial institutions in their M&A and other transactions involving Chinese entities/assets, as well as PRC entities in their outbound investments. Lu has also worked on some high-profile IPO transactions getting PRC companies listed overseas. Her expertise also encompasses areas such as regulatory compliance and employment matters. Lu most recently served as counsel at Akin Gump Strauss Hauer & Feld. Previously she was an associate at two other leading UK/US law firms, respectively (mainly at their Hong Kong office). She started her practice with one of the top PRC law firms. Lu is a graduate of Peking University (LLB 1996 and LLM, 1999) and Harvard Law School (LLM 2001). She is admitted to New York and Hong Kong Bars and also qualified to practice in the PRC.

K&L Gates has added Henry Wang and Jay Chiu as partners in its China offices. Wang arrives at the firm’s Beijing office from Mayer Brown JSM whilst Chiu joins the firm’s Hong Kong office from Goodwin Procter LLP, where he served as head of the Asian intellectual property and litigation practice. Joining the firm’s corporate and transactional practice area, Wang has 20 years of experience advising top-tier domestic and multinational corporations, financial institutions and private investors on a full range of corporate matters involving China. With a focus on outbound transactions, he frequently counsels Chinese companies seeking to establish or expand their business beyond mainland China. A former general counsel at General Motors, Shanghai, Wang is experienced in advising on the structure of domestic and cross-border M&As, corporate finance transactions, joint ventures and wholly foreign-owned entities, and licensing agreements and commercial contracts. On the other hand, Chiu joins the firm’s litigation and dispute resolution practice. With substantial experience in advising on complex litigation and intellectual property matters, including a focus on US patent litigation, contested Patent Office proceedings, licensing and counseling matters, Chiu will add to the firm’s already deep capabilities in cross-border technology deals and matters. Admitted in Hong Kong and California, he has more than 14 years of patent litigation experience, having represented a diverse range of technology clients, including computer, semiconductor, liquid crystal display, optical storage, software and telecom companies. In addition to guiding clients in pre-litigation analysis and negotiating licenses, Chiu also advises and acts for clients on commercial disputes, internal investigations, FCPA and international arbitration matters.

Norton Rose Fulbright has added Samantha Kelly as a partner in Sydney. She was a senior insurance partner at DLA Piper and predecessor firm DLA Phillips Fox. Kelly’s experience is in the defence of general liability and casualty claims, product liability, environmental liability and defamation. She has acted for top Australian and international insurers and companies, including in class action disputes, general civil litigation and royal commissions, coronial inquests and other bodies of inquiry.

White & Case has added David Albagli, PhD as a local partner in the global intellectual property practice. He will be based in Tokyo. Albagli brings extensive experience on a wide range of IP matters spanning patent litigation, prosecution, opinion work and patent portfolio strategy development, as well as pre-litigation counseling and due diligence investigations. He also advises on IP-related transactional matters and has significant hands-on experience as a patent attorney. His work on IP matters focuses on pharmaceuticals and biotechnology, and includes chemicals, polymers, medical devices and semiconductors. Albagli is also an experienced scientist with expertise in a wide range of fields, particularly in nucleic acid technologies, chemical synthesis, electrochemistry, microfluidics, polymers and biochemistry. He graduated from Princeton University and received his PhD from the Massachusetts Institute of Technology and his JD from the University of California Hastings. Albagli is qualified to practice in California and at the US Patent and Trademark Office. He is a registered foreign attorney in Japan (Gaikokuho Jimu Bengoshi) and a member of the Daiichi Tokyo Bar Association.

Latest Moves
Latest Articles